Plain-English translation of NCT05410977 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is evaluating a test called multitarget stool DNA (mt-sDNA) 2.0 to see if it can reliably detect colon cancer or precancerous polyps in people who have Lynch syndrome, a hereditary genetic condition. Researchers want to understand how accurate this stool test is compared to colonoscopy, the standard screening procedure. The study will also build a collection of blood and stool samples from Lynch syndrome patients to help scientists better understand early-onset colon cancer.
Lynch syndrome puts people at very high risk for colon cancer, often at younger ages than the general population. Current screening relies on colonoscopy, which is invasive and requires special preparation. This trial exists to see whether a simple stool test could be an effective screening tool to catch cancer or precancerous growths earlier in people with this genetic condition.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be asked to provide a blood sample and a stool sample around the time of your regular colonoscopy or flexible sigmoidoscopy — either up to 90 days before or 7 to 90 days after the procedure. Researchers will also review your medical records. The stool samples will be tested using the new test, and the results will be compared to what the doctor found during your procedure to see how accurate the test is. There are no additional visits or long-term follow-up beyond sample collection.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States